证券记录 · 已归档季度
ELV
Elevance Health Inc. · Healthcare
16被追踪持有人
-2Δ持有人
27.12M持有股份
$14.09B报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -11.1% ·
股份流向 -7.2% ·
净新建仓位 -12.5%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 688.09K | $266.91M | n/a | −2 |
| Q2 2026 | 176 | +1 | 154.58M | $59.72B | +7 | −8 |
| Q1 2026 | 180 | +5 | 158.67M | $46.48B | +9 | −5 |
| Q4 2025 | 174 | -3 | 171.19M | $60.01B | +1 | −3 |
| Q3 2025 | 26 | +3 | 90.20M | $29.15B | +4 | −2 |
| Q2 2025 | 21 | -2 | 85.20M | $33.13B | +1 | −3 |
| Q1 2025 | 20 | +1 | 41.04M | $17.85B | +2 | −1 |
| Q4 2024 | 19 | +2 | 43.15M | $15.91B | +2 | n/a |
| Q3 2024 | 16 | -2 | 27.12M | $14.09B | +1 | −3 |
| Q2 2024 | 18 | n/a | 29.21M | $15.82B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.15M | -12.8% | $5.28B | 0.6% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (被动) | 4.85M | +1.8% | $2.51B | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 4.46M | +6.9% | $2.32B | 0.4% | ▲ Add | 2 | SEC ↗ ×8 |
| 4 | Norges Bank ✦ (被动) | 2.98M | -2.4% | $1.55B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 2.77M | -3.3% | $1.44B | 1.1% | ▼ Trim | 2 | SEC ↗ ×4 |
| 6 | Arrowstreet Capital ✦ | 790.44K | -15.4% | $411.03M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 350.24K | +37.6% | $180.87M | 0.2% | ▲ Add | 2 | SEC ↗ ×4 |
| 8 | Millennium Management ✦ | 248.00K | -54.3% | $128.96M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 147.06K | -40.1% | $76.47M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 144.24K | +312.9% | $75.00M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 83.19K | 新增 | $43.26M | 0.0% | New | 1 | SEC ↗ ×2 |
| 12 | Bridgewater Associates ✦ | 62.05K | +49.2% | $32.27M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 55.07K | -77.1% | $28.63M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 14 | Gotham Asset Management ✦ | 26.65K | +125.6% | $13.86M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Dodge & Cox ✦ | 1.10K | 0.0% | $572,000 | 0.0% | Held | 2 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 838 | +3.8% | $436,069 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $43.26M | 0.0% |
已清仓
| Point72 Asset Management | $131.61M | 曾为 0.4% |
| Glenview Capital | $53.42M | 曾为 1.1% |
| Marshall Wace | $35.76M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,453 持有人, 194.60M 股份, $53.66B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 22
Kaye Mark
Officer · 273 股 · $122,083
Oct 22
Kaye Mark
Officer · 2.34K 股 · $1.03M
Oct 22
Kaye Mark
Officer · 480 股 · $212,453
Oct 22
Kaye Mark
Officer · 440 股 · $195,276
Oct 22
Kaye Mark
Officer · 160 股 · $71,176
Oct 22
Kaye Mark
Officer · 827 股 · $368,883
Oct 22
Kaye Mark
Officer · 400 股 · $173,600
Oct 22
Kaye Mark
Officer · 321 股 · $139,715
Oct 22
Kaye Mark
Officer · 1.66K 股 · $724,092
Oct 22
Kaye Mark
Officer · 560 股 · $244,759
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据